OTCMKTS:SCIE - SpectraScience Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week Range$0.0001 - $0.0002
Volume702,024 shs
Average Volume8.65 million shs
Market Capitalization$492,000.00
P/E RatioN/A
Dividend YieldN/A
SpectraScience, Inc. develops and markets a technology platform to instantly determine whether a tissue is normal, pre-cancerous, or cancerous without the need for a physical biopsy in the United States, Europe, and internationally. It offers WavSTAT3 optical biopsy system to determine whether a colon tissue is normal, pre-cancerous, or cancerous without physically removing tissue from the body; and WavSTAT4 optical biopsy system, a colon diagnostic product that operates by using UV laser light to optically illuminate and analyze tissue, enabling the physician to make an instant diagnosis during endoscopy when screening for cancer. The company also sells mobile consoles and disposable forceps. In addition, it engages in developing an esophageal diagnosis application for the detection of pre-cancerous and cancerous tissues in various tissues of the body. The company was formerly known as GV Medical, Inc. and changed its name to SpectraScience, Inc. in October 1992. SpectraScience, Inc. was founded in 1983 and is based in San Diego, California.

Receive SCIE News and Ratings via Email

Sign-up to receive the latest news and ratings for SCIE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment
Current SymbolOTCMKTS:SCIE



Sales & Book Value

Annual SalesN/A



Outstanding Shares4,923,795,000
Market Cap$492,000.00
Next Earnings DateN/A
OptionableNot Optionable

SpectraScience (OTCMKTS:SCIE) Frequently Asked Questions

What is SpectraScience's stock symbol?

SpectraScience trades on the OTCMKTS under the ticker symbol "SCIE."

Has SpectraScience been receiving favorable news coverage?

News articles about SCIE stock have trended somewhat positive this week, according to InfoTrie. The research firm identifies positive and negative press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. SpectraScience earned a news sentiment score of 0.8 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the immediate future.

Who are some of SpectraScience's key competitors?

What other stocks do shareholders of SpectraScience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SpectraScience investors own include Spectrum Brands (SPB), Dermira (DERM), Trimble (TRMB), Bloom Energy (BE), CytoDyn (CYDY), Sangamo Therapeutics (SGMO), Resources Connection (RECN), PARINGA RESOURC/S (PNRL), Matrix Service (MTRX) and Iridium Communications (IRDM).

Who are SpectraScience's key executives?

SpectraScience's management team includes the folowing people:
  • Mr. Michael P. Oliver, CEO, Pres, COO & Director (Age 71)
  • Mr. Lowell W. Giffhorn, CFO & Sec. (Age 72)

How do I buy shares of SpectraScience?

Shares of SCIE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How big of a company is SpectraScience?

SpectraScience has a market capitalization of $0.00. SpectraScience employs 5 workers across the globe.

What is SpectraScience's official website?

The official website for SpectraScience is http://www.spectrascience.com.

How can I contact SpectraScience?

SpectraScience's mailing address is 11568 SORRENTO VALLEY ROAD SUITE 11, SAN DIEGO CA, 92121. The company can be reached via phone at 858-847-0200.

MarketBeat Community Rating for SpectraScience (OTCMKTS SCIE)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  36 (Vote Outperform)
Underperform Votes:  37 (Vote Underperform)
Total Votes:  73
MarketBeat's community ratings are surveys of what our community members think about SpectraScience and other stocks. Vote "Outperform" if you believe SCIE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SCIE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/20/2019 by MarketBeat.com Staff

Featured Article: Cryptocurrencies

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel